The EVEDA HubX captures 150+ diagnostic data points across six vital organs using just five drops of blood and a urine sample. No venepuncture. No lab. No waiting.
Whether you're screening employees on a mine site, equipping a remote clinic in the Pacific, or distributing diagnostics across a country. EVEDA adapts.
Reduce absenteeism and health costs with onsite screening. 150+ tests in 15 minutes at a fraction of traditional pathology costs.
Explore corporate healthClose the gap in Indigenous health. Equip remote clinics, PHNs, and community health workers with portable diagnostic capability.
Government solutionsAdd point-of-care diagnostics to your pharmacy, clinic, or wellness business. White-label and co-branded models across Oceania.
Become a partnerDistribute EVEDA across the Pacific Islands, Southeast Asia, and beyond. Country-level partnerships with regulatory and training support.
Explore distributionFrom point-of-care data capture to patient engagement and population analytics, EVEDA connects every stage of the screening journey into one integrated platform.
Portable point-of-care screening captures 150+ data points across six vital organs in 15 minutes. Five drops of blood, no venepuncture, no lab.
Patient management, telehealth, appointment scheduling, billing, and clinical workflows, all in one platform for GPs and health services.
Patients own their health data. View results, track trends, share with their GP, manage prescriptions, and access diet and fitness modules.
De-identified, aggregated population insights. Health risk scoring, demographic trends, disease progression tracking, and longitudinal health dashboards.
Traditional corporate health screening requires venepuncture, external pathology labs, multiple appointments, and weeks of waiting. EVEDA delivers more tests, faster, onsite, at a fraction of the cost.
Calculate your savings
EVEDA's diagnostic accuracy is validated by leading international and Australian pathology quality programs. Our systems are certified to medical device, information security, and quality management standards.
Class IIb medical device system (ARTG 346638) and Class I clinical software (ARTG 342561) on the Australian Register of Therapeutic Goods
Diagnostic accuracy independently verified using Randox international quality controls, the global benchmark for clinical laboratory performance
Validated through the Royal College of Pathologists of Australasia Quality Assurance Program, the standard used by every major pathology lab in AU and NZ
Registered with New Zealand's medicines and medical devices safety authority for Oceania-wide deployment
Medical device quality management system and general quality management certified to international standards
Information security management system certified, protecting patient health data across cloud infrastructure
Five drops of capillary blood and a urine sample. No needles, no venepuncture. Under 2 minutes.
HubX processes 150+ data points across brain, heart, kidney, liver, lungs, and pancreas simultaneously.
Results appear in the Health Passport app within 15 minutes, accessible on any smartphone, shareable with your GP.
Health risk alerts and comorbidity insights guide immediate clinical decisions. Telehealth integration for remote review.
EVEDA's integrated platform is designed to shift healthcare from reactive treatment to proactive prevention, delivering clinical and operational value across every deployment setting.
Screening six vital organs simultaneously, brain, heart, kidney, liver, lungs, and pancreas, enables detection of chronic disease risk factors before symptoms present.
Results available in 15 minutes onsite, eliminating the 3–7 day wait for external pathology labs and enabling same-day clinical decisions and referrals.
Onsite screening removes the need for employees to attend external appointments, reducing absenteeism associated with health assessments and follow-up visits.
At 5.6kg with standalone power and satellite connectivity, HubX brings comprehensive screening to communities that would otherwise require costly patient transport to regional centres.
Regular comprehensive screening supports early intervention for chronic conditions, helping to prevent complications that lead to emergency presentations and hospital admissions.
De-identified, aggregated analytics through DAX enable organisations and health services to identify trends, target interventions, and measure program effectiveness at population scale.
EVEDA has been deployed across corporate, community, and remote health settings. Detailed case data is available under NDA for qualified evaluators.
Corporate health
A large-scale onsite screening program deployed across multiple sites in the Australian primary industries sector, delivering comprehensive health assessments to employees working in challenging environments.
Remote & community
Portable deployment to remote and regional communities where geography creates fundamental barriers to accessing traditional primary care and pathology services.
From a corporate office in Sydney to a remote atoll in the Pacific. HubX delivers the same comprehensive diagnostic capability.
Whether you're screening 50 employees or equipping a network of remote clinics, we'll show you exactly how EVEDA fits your operation.